Observational Study on the Management of Patients With Non Small Cell Lung Cancer (NSCLC) Adenocarcinoma Tested for the Activating Mutation of Epidermal Growth Factor Receptor Tyrosine Kinase (EGFR TK)
N/A
18 Years
N/A
18 Years
N/A
Not Enrolling
Both
Non Small Cell Lung Cancer
Both
Non Small Cell Lung Cancer
Trial Information
Observational Study on the Management of Patients With Non Small Cell Lung Cancer (NSCLC) Adenocarcinoma Tested for the Activating Mutation of Epidermal Growth Factor Receptor Tyrosine Kinase (EGFR TK)
MSD
Inclusion Criteria:
- Patient with lung cancer (Non Small Cell Lung Cancer adenocarcinoma)
- Patient for whom a search for the mutational status of EGFR (EGFR-M +, M- or Mx) has
been done or is being analyzed
Exclusion Criteria:
- Assessment of mutational status of EGFR is not done
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
The main objective of the study is to determine the proportion of patients with M + mutation status among patients with NSCLC adenocarcinoma
Outcome Time Frame:
At baseline
Safety Issue:
No
Principal Investigator
Corrine Bernaud, Medical Director
Investigator Role:
Study Director
Investigator Affiliation:
AstraZeneca
Authority:
France: French Data Protection Authority
Study ID:
NIS-OFR-DUM-2010/1
NCT ID:
NCT01167972
Start Date:
September 2010
Completion Date:
September 2012
Related Keywords:
- Non Small Cell Lung Cancer
- M + mutation
- Non Small Cell Lung Cancer adenocarcinoma
- To determine the proportion of patients with M + mutation status among patients with NSCLC adenocarcinoma
- Adenocarcinoma
- Adenocarcinoma, Mucinous
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
Name | Location |
|---|
